by Tawny Hammett, M.S. JHU Alumna The COVID-19 pandemic has transcended a mere influenza-like disease, showcasing a range of severity from mild cold symptoms to
by Yazmin I. Rovira Gonzalez, Ph.D., JHU Alumna CRISPR-Cas9 technology is a powerful tool for editing genomes, as it allows researchers to alter DNA sequences
John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone
Tawny Hammett, M.S. Individualized Genomics & Health Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of
Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger
Lawrence Jones, PhD- Johns Hopkins University Alumnus Universal vaccines may be a game changer for future infections. Researchers say a universal flu vaccine could be
The Hopkins Biotech Network Board Congratulates The Johns Hopkins University Class of 2020 and All Graduates #JHU2020 Affiliated with the Hopkins Biotech Network! A
Veta Obazenu, M.S. The World Health Organization (WHO) estimates that more than 1 billion people – one sixth of the world’s population — suffer from
By: Yazmin I. Rovira Gonzalez, Ph.D. Johns Hopkins Alumna Sometime during my third year of graduate school, I started to realize that I needed to
